肝内胆管癌精准检测专家共识(2024版)  

Expert consensus on precision detection of intrahepatic cholangiocarcinoma(2024 edition)

作　　者：中国抗癌协会肝癌专业委员会病理学组 中国抗癌协会肿瘤病理专业委员会肝脏病理学组 上海市抗癌协会肿瘤病理专业委员会 李增山 丛文铭 纪元 张欣 韩晶 盛霞[5] Pathology Group,Chinese Society of Liver Cancer of Chinese Anti-Cancer Association;Liver Pathology Group,Chinese Society of Pathology of Chinese Anti-Cancer Association;Tumor Pathology Committee of Shanghai Anti-Cancer Association,Shanghai 200032,China

机构地区：[1]不详 [2]空军军医大学西京医院病理科 [3]海军军医大学东方肝胆外科医院病理科 [4]复旦大学附属中山医院病理科 [5]复旦大学附属闵行医院病理科

出　　处：《临床肝胆病杂志》2025年第3期432-441,共10页Journal of Clinical Hepatology

基　　金：上海市科学技术委员会项目(22JC1403002)。

摘　　要：肝内胆管癌(ICC)是一种高度异质性的肿瘤,分子分型是实施ICC个体化治疗的基础。正确的检测方法对于全面筛选适用靶向药物的患者群体具有重要的临床意义。本共识基于国内外临床实践数据,并结合中国国情,围绕ICC重要靶点进行制定,提出了15条推荐意见,以期为ICC的精准检测提供参考。Intrahepatic cholangiocarcinoma(ICC)is a highly heterogeneous tumor,and molecular profiling serves as the foundation for personalized treatment of ICC.Accurate detection methods are clinically significant for comprehensively screening patients suitable for targeted therapies.This consensus is based on clinical practice data from both domestic and international sources,tailored to the Chinese context,and focuses on key targets for ICC.We present 15 recommendations aimed at guiding the precision detection of ICC.

关 键 词：肝内胆管癌 精准检测 生物标志物 个体化治疗 

分 类 号：R73[医药卫生—肿瘤]